Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.
about
Exposure to endocrine disruptor induces transgenerational epigenetic deregulation of microRNAs in primordial germ cellsMixture Effects of Estrogenic Pesticides at the Human Estrogen Receptor α and βRole of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.Chronic low-dose exposure to a mixture of environmental endocrine disruptors induces microRNAs/isomiRs deregulation in mouse concomitant with intratesticular estradiol reductionCardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesActivation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN genemiRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.Sexually dimorphic effects of gestational endocrine-disrupting chemicals on microRNA expression in the developing rat hypothalamus.Diagnostic, prognostic and predictive value of MicroRNA-21 in breast cancer patients, their daughters and healthy individuals.Noncoding RNA response to xenobiotic exposure: an indicator of toxicity and carcinogenicity.Implication of microRNA deregulation in the response of vertebrates to endocrine disrupting chemicals.Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines.High N-acetyltransferase 1 (NAT1) expression is associated with estrogen receptor expression in breast tumors, but is not under direct regulation by estradiol, 17beta-diol, or dihydrotestosterone in breast cancer cells.Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
P2860
Q28546600-FB92E49B-8F1C-46FF-B43C-7220F52662BDQ28552908-A6F544DA-9890-4042-B593-4CDF4BBD885DQ33618824-AB80CFFD-7933-4A47-8232-35D56019C967Q33794251-0746AC19-4BFE-41B6-9707-58AAEDAEF900Q34391443-0BAE522B-AA91-4A45-BB62-EA44F485CE09Q34443746-97D31CCF-30E5-4683-9B6B-35A07306235EQ35912303-08F5647B-5E15-45A7-A7AD-3D3EE9FAD80BQ36006006-447F28CD-BEE9-4847-8F54-DC3E53F40098Q36057142-ED71B6F8-D67D-4121-AF67-875CFD5F8976Q38244618-DF519F59-8926-4D34-A1F4-03A6F761EFA3Q38485758-F1FCBD97-D137-4A8E-A2DB-E1F68DE33B77Q38891898-CC883522-7ECE-4709-91DD-CE2E97894110Q48232407-DC71F72B-518D-4C79-91DD-F561D02AC79EQ51563369-17759C35-8137-468C-9068-30BF314C2A3A
P2860
Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Endocrine disruptors fludioxon ...... ession in breast cancer cells.
@ast
Endocrine disruptors fludioxon ...... ession in breast cancer cells.
@en
type
label
Endocrine disruptors fludioxon ...... ession in breast cancer cells.
@ast
Endocrine disruptors fludioxon ...... ession in breast cancer cells.
@en
prefLabel
Endocrine disruptors fludioxon ...... ession in breast cancer cells.
@ast
Endocrine disruptors fludioxon ...... ession in breast cancer cells.
@en
P2093
P2860
P356
P1476
Endocrine disruptors fludioxon ...... ession in breast cancer cells.
@en
P2093
Svjetlana Medjakovic
Tissa T Manavalan
P2860
P356
10.1093/TOXSCI/KFS290
P577
2012-10-10T00:00:00Z